Tweets
Have a Rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
https://t.co/MMHvtkbz9l https://t.co/3aNijNJWkW
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
FDA Approves Citrate-Free Formulation of Hyrimoz, a Biosimilar to Humira - but adalimumab-adaz HCF wont be available in USA until July 1, 2023 https://t.co/RRjxPW5I4O https://t.co/hf6NlkGG7W
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Polypharmacy Increased in Psoriatic Arthritis
Psoriatic arthritis (PsA) is plagued by obesity, depression and increased comorbidities; now it appears that polypharmacy adds to the burden of managing PsA.
https://t.co/vispc9ei51 https://t.co/s45Nmpf46P
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
A Pilot Trial of Anifrolumab in Discoid Lupus
A research report in JAMA Dermatology describes the use of the type 1 interferon receptor inhibitor anifrolumab in patients with chronic discoid lupus erythematosus (DLE).
https://t.co/8OZqRvD1Lv https://t.co/T7dWQWc1gX
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
The AURORA study with voclosporin has changed the way that Dr. Kalunian practices. He now uses lower doses of steroid, 40mg in induction with a faster taper in lupus nephritis. #RNL2023 @RheumNow https://t.co/8ss14Z5WXl
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 3 months ago
⚠️Beware not all bone marrow oedema =#AxSpA on MRI !
Signal seen in 17% volunteers at SIJs
@DrPoddubnyy
#RNL2023 https://t.co/rksQin3tmD
Dr Gurdeep Dulay @gurdeep_dulay ( View Tweet )
3 years 3 months ago
Future treatment for #AxSpA ?
Promising data for #Bimekizumab
Inhibits IL-17 A and F
#RNL2023 https://t.co/H2euMPgIFj
Dr Gurdeep Dulay @gurdeep_dulay ( View Tweet )
3 years 3 months ago
Dr. John Reveille on genetic sharing between AS, PsO, and IBD
- multiple overlapping genetic signals
@RheumNow #RNL2023 https://t.co/p3gvfTO732
Robert B Chao, MD @doctorRBC ( View Tweet )
3 years 3 months ago
Late onset Inflammatory back pain?, Reveille #RNL2023 @RheumNow https://t.co/G0LOgjmBvj
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
3 years 3 months ago
Reassuring data by Dr. Laurent Arnaud on HCQ
- arrhythmia risk from HCQ similar to general population
@RheumNow #RNL2023 https://t.co/vMDg2SlbJQ
Robert B Chao, MD @doctorRBC ( View Tweet )
3 years 3 months ago
Great tips for #AxSpA monitoring
and
🚩 red flags for radiographic progression 🚩
❌No need for routine imaging follow-up
#RNL2023 @deodhara https://t.co/PAFtHIrqRF
Dr Gurdeep Dulay @gurdeep_dulay ( View Tweet )
3 years 3 months ago
A Pilot Trial of Anifrolumab in Discoid Lupus
A research report in JAMA Dermatology describes the use of the type 1 interferon receptor inhibitor anifrolumab in patients with chronic discoid lupus erythematosus (DLE).
https://t.co/MwruMhmvPq https://t.co/WnCvCZtq6z
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
